Next Article in Journal
Characterisation of Coastal Sediment Properties from Spectral Reflectance Data
Previous Article in Journal
Development and Testing of Copper Filters for Efficient Application in Half-Face Masks
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Zinc(II) Sulfanyltribenzoporphyrazines with Bulky Peripheral Substituents—Synthesis, Photophysical Characterization, and Potential Photocytotoxicity

by
Patrycja Koza
1,2,*,
Tomasz Koczorowski
1,
Dariusz T. Mlynarczyk
1 and
Tomasz Goslinski
1,*
1
Chair and Department of Chemical Technology of Drugs, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznań, Poland
2
Doctoral School, Poznan University of Medical Sciences, Bukowska 70, 60-812 Poznań, Poland
*
Authors to whom correspondence should be addressed.
Appl. Sci. 2022, 12(13), 6825; https://doi.org/10.3390/app12136825
Submission received: 11 May 2022 / Revised: 10 June 2022 / Accepted: 27 June 2022 / Published: 5 July 2022
(This article belongs to the Special Issue Contributions of Women in the Photocatalysis Field)

Abstract

:
The study’s aim was to synthesize new unsymmetrical sulfanyl zinc(II) porphyrazines and subject them to physicochemical and electrochemical characterization and also an initial acute toxicity assessment. The procedure was initiated from a commercially available dimercaptomaleonitrile disodium salt and o-phthalonitrile using Linstead’s macrocyclization reaction conditions, which led to magnesium(II) tribenzoporphyrazine with 4-(3,5-dibutoxycarbonylphenoxy)butylthio substituents. The obtained macrocycle was demetallated with trifluoroacetic acid and subsequently remetallated with zinc(II) acetate toward the zinc(II) porphyrazine derivative. The zinc(II) tribenzoporphyrazine with 4-(3,5-dibutoxycarbonylphenoxy)butylthio substituents was then subjected to the reduction reaction with LiAlH4, yielding zinc(II) tribenzoporphyrazine with 4-[3,5-di(hydroxymethyl)phenoxy]butylthio substituents. The new zinc(II) tribenzoporphyrazines were characterized by UV-Vis spectroscopy, various NMR techniques (1HNMR, 13CNMR, 1H-1H COSY, 1H-13C HSQC, and 1H-13C HMBC), and mass spectrometry. In the UV-Vis spectra, both macrocycles revealed characteristic Soret and Q-bands, whose positions were dependent on the solvent used for the measurements. Zinc(II) tribenzoporphyrazines were studied using electrochemical and photochemical methods, including the singlet oxygen generation assessment. Both zinc(II) porphyrazines revealed high singlet oxygen generation quantum yield values of up to 0.59 in DMSO, which indicates their potential photosensitizing potential for photodynamic therapy. In addition, new derivatives were subjected to a Microtox® bioluminescence assay.

1. Introduction

Synthetic analogues of naturally occurring porphyrins are porphyrazines (Pzs). The macrocyclic core of Pzs consists of four pyrrole rings linked together by azamethine bridges [1]. Pzs reveal unique spectroscopic, photochemical, and electrochemical properties that make them suitable for potential applications in technology and medicine [2,3,4,5]. The absorption of light in the range of 650–850 nm, which is often described as the phototherapeutic window, as well as the generation of reactive oxygen species in the photodynamic reaction, make Pzs especially relevant for medical applications, in particular photodynamic therapy (PDT) [6]. The PDT principle is based on the photodynamic reaction, which starts from the exposure of the photosensitizer to light of an appropriate wavelength [7]. Upon irradiation, the photosensitizer situated in a specific tumor tissue is activated from the ground singlet state to the first excited state and next, by the chain of transitions, to the triplet state. The presence of the macrocyclic molecule in its triplet state is vital for the production of reactive oxygen species (ROS), including singlet oxygen (1O2), further initiating apoptotic or necrotic cell death. The most commonly used photosensitizers in PDT are porphyrins and their derivatives [8]. Nevertheless, many years of research on porphyrazines have also shown their great potential for future PDT applications.
The lipophilic properties of Pzs are particularly beneficial, as cancer cells often overexpress LDL receptors, which could increase the effectiveness of the therapy [9]. However, the lipophilic character of Pzs could also constitute the main obstacle for prospective applications of Pzs in PDT. This is because the non-polar macrocyclic core of Pzs decreases their solubility in water, thus increasing their ability to form aggregates in polar solvents, which in turn hampers their ability to produce ROS. The increase in the solubility of Pzs can be indirectly achieved by incorporating these macrocycles into different drug-delivery systems, such as liposomes [10,11,12,13] or polymers [14,15,16,17]. Nevertheless, the direct and practical possibility of solubility improvement of these compounds is possible due to the substitution of the Pz core in the peripheral positions. In this regard, sulfanyl peripheral substituents attached to the porphyrazine macrocycle can significantly enhance the solubility of these macrocycles in various solvents [18,19]. Both sulfanyl porphyrazines and tribenzoporphyrazines can be prepared using Linstead’s macrocyclization reaction conditions. As stated before by our group [20], sulfanyl porphyrazines reveal low to moderate singlet oxygen generation efficacies. A tribenzoporphyrazine analogue with terminal hydroxyl groups at the periphery has presented the highest generation of singlet oxygen (ϕ = 0.20) and excellent photocytotoxicity, which can be related to its solubility and localization. Therefore, in our current study, we present the synthesis of new unsymmetrical sulfanyl zinc(II) porphyrazines, their physicochemical characterization, and an initial acute toxicity assessment.

2. Materials and Methods

2.1. General Procedures

All reactions were carried out in oven-dried glassware under an inert gas atmosphere. When needed, Radley’s Heat-On heating system was used. Solvents were evaporated by using a rotary evaporator at or below 60 °C under reduced pressure. Reagents and solvents were used without purification and were obtained from commercial suppliers, i.e., Sigma-Aldrich, Fluka, POCh, and Merck. Thin-layer chromatography (TLC) was performed on silica gel Merck Kieselgel 60 F254 plates and visualized by UV light. The NMR spectra (1HNMR, 13CNMR, 1H-1H COSY, 1H-13C HSQC, and 1H-13C HMBC) were recorded using a full-fledged, two-channel 400 MHz Bruker AvanceCore NMR spectrometer. The mass spectra were recorded using the ESI method on a Bruker Impact HD by the Wielkopolska Centre for Advanced Technologies in Poznań.

2.2. Synthetic Procedures

The precursor compounds, dimethyl 5-(4-bromobutoxy)isophthalate (1) and 2,3-bis[4-(3,5-dimethoxycarbonylphenoxy)butylsulfanyl]maleonitrile (2), and the magnesium(II) tribenzoporphyrazine derivatives, 22,23-bis[4-(3,5-dibutoxycarbonylphenoxy)butylthio]-tribenzo[b,g,l]porphyrazinato magnesium(II) (3) and 22,23-bis{4-[3,5-di(hydroxymethyl)phenoxy]butylthio}tribenzo[b,g,l]porphyrazinato magnesium(II) (4), were synthesized using previously published procedures [18,20]. Metal-free tribenzoporphyrazine 22,23-bis[4-(3,5-dibutoxycarbonylphenoxy)butylsulfanyl]tribenzo[b,g,l]porphyrazine was synthesized according to the literature procedure [21].

2.2.1. 22,23-Bis[4-(3,5-dibutoxycarbonylphenoxy)butylthio]-tribenzo[b,g,l]porphyrazinato Zinc(II) (6)

Magnesium(II) porphyrazine derivative 3 (107 mg, 0.086 mmol) was suspended in trifluoroacetic acid (5 mL) and stirred for 30 min in the dark at room temperature. The suspension was poured into an ice–water mixture, then neutralized with a saturated solution of sodium bicarbonate and extracted with dichloromethane. The organic layers were combined, the organic solvent was evaporated, and the dark blue solid residue was then subjected to column chromatography (dichloromethane/methanol 20:1) [21]. Metal-free Pz derivative 5 (92 mg, 0.075 mmol), N,N-dimethylformamide (DMF, 25 mL), and zinc(II) acetate (41 mg, 0.225 mmol) were stirred in a round-bottomed flask under inert gas at 70 °C for 24 h. After that, the solvent was evaporated, and the residual blue oil was subjected to column chromatography (dichloromethane/methanol 50:1 then 20:1), leading to a cerulean blue product 6 (79 mg, 71% yield). Rf = 0.71 (dichloromethane/methanol, 20:1, v/v). UV-Vis (dichloromethane) λmax nm (log ɛ) 227 (4.84), 352 (4.69), 649 (4.73), 692 (4.89). 1HNMR (400 MHz, pyridine-d5) δ 9.65–9.70 (m, 4H, tribenzo-H), 9.58 (2d, J = 8 Hz, 2H, tribenzo-H), 8.31 (s, 2H, isophtalate-H), 8.26 (2d, J = 5.5 Hz, 2H, tribenzo-H), 8.18–8.23 (m, 4H, tribenzo-H), 7.55 (s, 4H, isophtalate-H), 4.67 (t, J = 7 Hz, 4H, PhOCH2), 4.22 (t, J = 7 Hz, 8H, C(O)OCH2), 4.00 (t, J = 6 Hz, 4H, SCH2), 2.26–2.39 (m, 8H, SCH2CH2CH2), 1.48–1.55 (m, 8H, CH2CH2CH3), 1.22–1.31 (m, 8H, CH2CH3), 0.79 (t, J = 7 Hz, 12H, CH3). 13C NMR (101 MHz, pyridine-d5) δ 165.7 (C = O), 159.6, 158.3, 157.8, 154.4, 153.5, 140.3, 140.1, 139.4, 138.7, 132.6, 131.1, 130.9, 130.4, 119.8, 68.3 (SCH2CH2), 65.6 (OCH2CH2CH2CH3), 35.7 (CH2CH2O), 31.1 (CH2CH2CH3), 28.9 (SCH2CH2CH2), 27.8 (SCH2CH2CH2), 19.7 (CH2CH3), 14.1 (CH3). MS (ESI): m/z: calcd. (C68H71N8O10S2Zn): 1287.4020 [M + H]+, found: 1287.4015.

2.2.2. 22,23-Bis{4-[3,5-di(hydroxymethyl)phenoxy]butylthio}tribenzo[b,g,l]porphyrazinato Zinc(II) (7)

Lithium aluminum hydride (13 mg, 0.353 mmol) was suspended in tetrahydrofuran (THF) precooled to 0 °C and stirred for 30 min. Porphyrazine derivative 6 (95 mg, 0.074 mmol) was dissolved in THF (14 mL), and the solution was added dropwise to the reaction mixture over 40 min. Next, the combined reagents were stirred for another 2 h at room temperature. After that, the saturated solution of NH4Cl (5 mL) was added, and the reaction mixture was stirred for 15 min. The reaction mixture was filtered through Celite, which was additionally washed with dichloromethane. Next, all solvents were evaporated to dryness using a rotary evaporator. Peacock blue residue was chromatographed (dichloromethane/methanol 20:1) to give 7 (67 mg, 90% yield) as a dark sapphire blue film. Rf = 0.62 (dichloromethane/methanol, 20:1, v/v). UV-Vis (dichloromethane) λmax nm (log ɛ) 227 (4.76), 358 (4.59), 629 (4.45), 725 (4.55). 1H NMR (400 MHz, pyridine-d5) δ 9.46–9.58 (m, 4H, tribenzo-H, isophtalo-H), 8.19–8.41 (m, 6H, tribenzo-H, isophtalo-H), 7.35–7.67 (m, 6H, tribenzo-H, isophtalo-H), 4.18–4.26 (s, 4H, OCH2CH), 2.15–2.42 (m, 4H, SCH2CH2), 1.48–1.55 (m, 4H, SCH2CH2CH2), 1.20–1.34 (m, 4H, SCH2CH2CH2), 0.90–0.97 (m, 8H, CH2OH). 13C NMR (101 MHz, pyridine-d5) δ 165.8, 165.5, 159.7, 140.3, 132.8, 132.4, 123.0, 124.5, 122.5, 122.7 119.9, 119.5, 67.8 (SCH2), 53.7 (CH2O) 31.1 (SCH2CH2), 19.7, 14.2 (CH2OH). MS (ESI): m/z calcd. (C52H47N8O6S2Zn): 1007.2346 [M + H]+, found: 1007.2351.

2.3. UV/Vis Measurements

All solutions containing macrocycles 6 and 7 were prepared before their absorbance measurements. UV-Vis absorption spectra were recorded using a JASCO 770 spectrophotometer in the wavelength range from 190 to 800 nm. Solvatochromic studies were collected in 12 solvents: dichloromethane (DCM), chloroform, acetone, diethyl ether, ethyl acetate, acetonitrile, 1,4-dioxane, THF, 1-butanol, toluene, dimethyl sulfoxide (DMSO), and DMF using the same quantity of either 6 or 7 in each solvent.

2.4. Electrochemical Measurements

Electrochemical experiments were performed with a Metrohm Autolab PGSTAT128N potentiostat connected to a PC for data acquisition and storage, driven by Metrohm Nova 2.1.4 software. The setup for organic measurements in dichloromethane consisted of the glassy carbon (GC) working electrode (area = 0.071 cm2), an Ag wire as the pseudo-reference electrode, and a platinum wire as the counter electrode. Before each experiment, the GC electrode was polished with an aqueous 50 nm Al2O3 slurry (provided by Sigma-Aldrich, St. Louis, MI, USA,) on a polishing cloth, followed by subsequent washing in an ultrasonic bath with deionized water for 10 min in order to remove inorganic impurities. A ferrocenium/ferrocene couple (Fc+/Fc) was used as an internal standard. Before the experiments, a glass cell (volume 10 mL) containing the solution sample with a supporting electrolyte (0.1 M tetrabutylammonium perchlorate, TBAP) was deoxygenated by purging nitrogen gas. All electrochemical experiments were carried out at ambient laboratory temperature. DCM and TBAP were purchased from Sigma-Aldrich.

2.5. Singlet Oxygen Generation Study

A singlet oxygen generation study was performed following the previously described method [22]. 1,3-Diphenylisobenzofuran (DPBF) was applied as a chemical quencher (Sigma-Aldrich) for singlet oxygen generation measurements. New porphyrazines 67 and the quencher were exposed to light at the appropriate wavelength (665 nm) and examined by UV-Vis. As a reference, zinc(II) phthalocyanine (ZnPc) was used with a known singlet oxygen quantum yield (0.67 in DMSO) [23,24].

2.6. Acute Toxicity Assessment

The acute toxicity test for the dark toxicity assessment was performed following the 81.9% screening test procedure supplied by the manufacturer and measured with a Microtox® M500 with Modern Water MicrotoxOmini 4.2 software. The tested macrocycles were dissolved in DMSO and diluted to the appropriate concentrations with water. The DMSO concentration was lower than 1%, which was confirmed not to interfere with the results.
The photocytotoxicity was evaluated by slightly modifying the procedure [25]. Upon the addition of the sample to the bacterial suspension, an LED lamp was placed above the test cuvettes (λmax = 665 nm, 7 mW/cm2).

3. Results and Discussion

3.1. Synthesis and Characterization

In the first step, commercially available dimercaptomaleonitrile disodium salt and o-phtalonitrile were applied to Linstead’s macrocyclization reaction conditions, which led to magnesium(II) tribenzoporphyrazine with 4-(3,5-dibutoxycarbonylphenoxy)butylthio substituent 3 (Scheme 1) [26,27]. This macrocycle was subjected to the reduction reaction with LiAlH4, which led to magnesium(II) tribenzoporphyrazine with 4-[3,5-di(hydroxymethyl)phenoxy]butylthio substituents 4 [28]. Tribenzoporphyrazine derivatives 3 and 4 were obtained according to the previously published procedure and purified using flash column chromatography [20]. Macrocycle 3 was treated with trifluoroacetic acid, leading to the demetallated derivative [21] and then was subsequently remetallated with zinc(II) acetate toward zinc(II) tribenzoporphyrazine with 4-(3,5-dibutoxycarbonylphenoxy)butylthio substituent 6. Next, Pz 6 was subjected to the reduction reaction with LiAlH4, which allowed zinc(II) tribenzoporphyrazine with 4-[3,5-di(hydroxymethyl)phenoxy]butylthio substituents 7 to be obtained. The new zinc(II) tribenzoporphyrazines 6 and 7 were characterized using UV-Vis spectroscopy, various NMR techniques (1HNMR, 13CNMR, 1H-1H COSY, 1H-13C HSQC, and 1H-13C HMBC), and mass spectrometry. The NMR data concerning the analysis of chemical shifts and key observed correlations are included in the Supplementary Materials.

3.2. Absorption Properties of New Porphyrazines

As was stated by C. F. van Nostrum et al., the metal ions in the coordination centers and the peripheral substituents strongly influence the electronic absorption spectra of the porphyrinoids [29]. In general, in the spectra of Pzs, two characteristic bands can be observed, the Soret band (B-band) in the range of 300–400 nm and the Q-band in the range of 600–850 nm [29,30,31,32]. The Q-bands that appeared in the spectra of both Pzs 6 and 7 recorded in different solvents are presented in Figure 1. Following the data presented in Table 1, the Soret maxima of 6 and 7 appeared in the ranges of 337–361 and 338–366 nm, whereas the Q-bands were present in the ranges of 681–701 and 682–723 nm, respectively. The Q-band positions reflect the effects of π-π* electron transitions from HOMO (highest occupied molecular orbital) to LUMO (lowest unoccupied molecular orbital) and constitute a characteristic feature of the studied macrocycles. The Q-bands of obtained Pzs 6 and 7 are split into two components, Qx and Qy, which could result more from their decreased symmetry than the formation of aggregates. The Soret-band position is also a consequence of π-π* transitions but from the molecular orbital (MO) to LUMO. The slight modifications of the 6 and 7 peripheries as well as the solvent choice significantly affected the positions of the B- and Q-bands in the UV-Vis spectra. The main difference was the distances between the Qx and Qy components of the Q-bands form, which were approximately 43 nm for 6 and 94 nm for 7 in dichloromethane. In addition, peripheral sulfur atoms could also influence the photophysics of both Pzs. Following the literature, in the magnesium(II) octacarboranyl(hexylsulfanyl)porphyrazine UV-Vis spectra, an additional absorption band at approximately 500 nm was noted as a result of nsulfur-π* transitions [33]. Such phenomena were noted in the spectra of 6 measured in DCM and ethyl acetate and in the spectra of 7 recorded in DCM and acetonitrile.

3.3. Solvatochromic Studies

In the UV-Vis spectra of 6 (Figure 1a) and 7 (Figure 1b) recorded in dichloromethane, acetone, chloroform, diethyl ether, and ethyl acetate, intense Q-bands were considerably split into two components. The split was less marked for the other solvents, such as acetonitrile, toluene, THF, 1,4-dioxane, 1-butanol, DMF, and DMSO. Therefore, solvent effects on UV-Vis absorption spectra were studied in selected protic and aprotic solvents. In the Q-band region, depending on the applied solvent, the positions and intensities of the bands were influenced. For 6, the largest red shift was noted in toluene, whereas the highest blue shift was observed in DMSO. For 7, the largest red shift was noted in dichloromethane, and the highest blue shift was observed in 1,4-dioxane, DMF, and DMSO.
To evaluate the solvatochromic effects, the correlation between the refractive indices of solvents and Q-band shifts was tested [24,34,35]. The 1/F value is a rational function of the solvent’s refractive index (n), which is calculated from the equation:
F = n 2 1 2 n 2 + 1
The wavelength (λmax in nm), representing the maximum of the Q-band, was plotted against 1/F. For tribenzoporphyrazine derivative 6, the linear correlation characterized by the correlation index (R2) of 0.86 (Figure 2a) was calculated for 8 out of 12 solvents, such as dichloromethane, acetone, chloroform, diethyl ether, ethyl acetate, acetonitrile, toluene, and THF. For macrocycle 7, the linear correlation index (R2) of 0.82 (Figure 2b) was found for the following solvents: diethyl ether, ethyl acetate, THF, 1,4-dioxane, DMF, and DMSO. Notably, the Q-band wavelengths of 6 and 7 in selected solvents were also correlated with the dipole moments. For tribenzoporphyrazine 6, the linear correlation index (R2) of 0.91 (Figure 3a) was noted for 6 out of 12 solvents: dichloromethane, acetone, chloroform, toluene, THF, and DMSO. The correlation between the dipole moment of the solvent and the λmax of the Q-band for compound 7 was calculated as a value of 0.94 (Figure 3b) for solvents such as acetone, ethyl acetate, acetonitrile, toluene, DMF, and DMSO. The outcomes of the solvatochromic study performed for 6 and 7 might suggest that the red shift of the Q-band can be the result of the coordinating strength of the solvent or solvation. The amount of data considered for both plots (Q-band vs. refractive index and Q-band vs. dipole moment) is related to the best R2. Adding more solvents decreased the significance of the obtained results. The data used for calculations, i.e., the absorption maxima of 6 and 7 as well as the values of the refractive indices (nD) and dipole moments (µ) in the applied solvents, are presented in Table 2.

3.4. Electrochemical Studies

The electrochemical measurements were performed using two zinc(II) tribenzoporphyrazine derivatives, 6 and 7, to assess their electroactivity towards potential uses as semiconductors or electrocatalysts. The cyclic voltammetry (CV) and differential pulse voltammetry (DPV) studies were applied in the classic three-electrode system with the glassy carbon working electrode, a platinum wire as a counter electrode, and a silver wire as a pseudo-reference. Due to the insolubility of Pzs 6 and 7 in water, the measurements were performed in dichloromethane with the addition of a tetrabutylammonium perchlorate (TBAP) electrolyte (0.1M). Ferrocene was used as an internal standard, and all voltammograms were adjusted to the ferrocenium/ferrocene peak potential. The CV scans were performed in the range of 25–200 mV/s.
In the voltammogram of 6, two reduction peaks and one oxidation peak were observed in the electrochemical window between −2.0 V and +1.0 V. The second oxidation peak was not noted in the CV scans (Figure 4a). However, its evolution was observed at the boundary of the electrochemical window in the DPV scan (Figure 4b). All redox peaks were correlated with the oxidation or reduction of the macrocycle ring due to the presence of the electrochemically inactive zinc(II) cation inside the core.
The CV and DPV studies of 7, which is a reduced derivative of Pz 6, revealed four redox peaks: two reductions and two oxidations in the investigated potential window (Figure 5). Within the first reduction peak, an additional descending peak can be observed related to the aggregation phenomenon of the studied porphyrazine, which is commonly observed in the voltammograms of other porphyrinoids in dichloromethane. The electrochemical data of Pzs 6 and 7 are presented in Table 3. A positive shift of 0.1 V of peak potentials for Pz 7 compared to Pz 6 was noticed. It may be a result of replacing electron-withdrawing groups (ester groups) with electron-donating groups (hydroxymethyl groups). In both cases, the electrochemical bandgap, Egap, presented the same value of 1.5 eV.
The obtained electrochemical data for Pz 6 were compared to its symmetrical analogue, an octasubstituted porphyrazine synthesized previously by our group [36], which was previously subjected to CV and DPV measurements in the same conditions as presented here. For the symmetrical zinc(II) sulfanyl porphyrazine with peripheral isophthaloxybutylsulfanyl substituents, the first reduction peak occurred at −1.01 V, while the first oxidation was noted at 0.67 V [36]. Considering this data, the redox processes were positively shifted in the symmetrical derivative, and the electrochemical bandgap was slightly higher in comparison to the unsymmetrical macrocycle 6 as a result of the presence of more electron-withdrawing ester groups in the macrocycle. Another example constitutes a symmetrical zinc(II) sulfanyl porphyrazine with (morpholin-4-yl)ethyl peripheral groups, which was studied in DCM/0.1M TBAP with ferrocene as an internal standard. In this case, the first redox peak was even more positively shifted in comparison to 6 and 7 [37]. However, the absence of aromatic peripheral substituents resulted in a lower electrochemical bandgap, unlike the case of the other macrocycles studied in this paper.
What is more, all oxidation and reduction processes in 6 (Figure 6a) and 7 (Figure 6b) are diffusion-controlled due to a linear correlation of the peak currents of the redox pairs versus the square root scan rate.

3.5. Singlet Oxygen Generation Study

To assess the potential application of the new tribenzoporphyrazines in photodynamic therapy, the quantum yields of singlet oxygen generation in DMSO were measured spectrophotometrically using an indirect method with 1,3-diphenylisobenzofuran (DPBF). DPBF is a compound that easily reacts with singlet oxygen, with a breakage of furan ring, and its peak at about 400 nm decreases over time (Figure 7 and Figure 8) as it decomposes. The changes in absorption were than calculated to give singlet oxygen quantum yields (Φ). As a reference, zinc(II) phthalocyanine was used. Compound 6 generated oxygen with a quantum yield value of 0.24, which indicates the moderate photosensitizing potential, whereas 7 presented an even higher quantum yield, reaching the value of 0.59. The measured singlet oxygen generation values can be considered as high compared to those previously obtained for the studied magnesium(II) 3 and 4 analogs and other porphyrazine derivatives presented in the literature (Table 4). It was found by Gierszewski et al. [38] that porphyrazines with eight peripheral isophtaloxyalkylsulfanyl substituents generate singlet oxygen with Φ values between 0.01 and 0.04 in DMF and that incorporating Mg2+ ions into the Pzs improves their capability to generate single oxygen. The exchange of Mg2+ (3, 6) to Zn2 (4, 7) in the tribenzoporphyrazine ring influenced the singlet oxygen generation quantum yield values, which increased from 0.05 (3) to 0.24 (4) and from 0.20 (6) to 0.59 (7). In Figure 7 and Figure 8, the Q-bands of 6 and 7 demonstrate only minimal to no changes during irradiation, thus indicating their good stability during measurements.

3.6. Ecotoxicity Assessment

In the acute toxicity test, the changes in bioluminescence are correlated with Aliivibrio fischeri bacterial metabolism. The luminescence linearly decreases with the increasing toxicity of an added sample. Compounds 4 and 6 induced no changes in the cell viability after exposure to red light in comparison to dark conditions, as can be seen in Figure 9. Quite the opposite effect can be observed for 3 and 7, in which case the cell viability was lower after irradiation. On the other hand, the values obtained for 3 present much higher variability, which suggests that they should be treated with caution. Additionally, such results are somewhat unusual, as they cannot be associated with higher singlet oxygen generation yields (Table 4). However, it can be seen that in all cases the higher concentration of the macrocycles (10−4 M) induced dark toxicity. Based on the results obtained earlier for the magnesium derivatives on bacterial strains and cancer cell lines [20,39], this toxic effect was probably caused by the absorption of the emitted bacterial bioluminescence at 490 nm by the macrocycles or was a result of the specificity of the test.

4. Conclusions

In summary, two new zinc(II) tribenzoporphyrazines with sulfanyl substituents were obtained and subjected to various photophysical measurements as well as an initial acute toxicity assessment. The results were compared to their magnesium(II)-containing counterparts. The synthesis started from obtaining a maleonitrile derivative according to the published procedure, then using this compound and the excess of 1,2-dicyanobenzene in Linstead’s macrocyclization reaction conditions resulted in the formation of magnesium(II) tribenzoporphyrazine with 4-(3,5-dibutoxycarbonylphenoxy)butylthio substituents. Next, the magnesium derivative was demetallated with trifluoroacetic acid and subsequently remetallated with zinc(II) acetate toward zinc(II) tribenzoporphyrazine. The next step of the synthesis was the peripheral modification, as zinc(II) tribenzoporphyrazines was subjected to a reduction reaction with LiAlH4, which led to zinc(II) tribenzoporphyrazine with 4-[3,5-di(hydroxymethyl)phenoxy]butylthio substituents. The new zinc(II) tribenzoporphyrazines were characterized by UV-Vis spectroscopy, various NMR techniques (1HNMR, 13CNMR, 1H-1H COSY, 1H-13C HSQC, and 1H-13C HMBC), and mass spectrometry. The UV-Vis spectra of the new macrocycles were recorded in different solvents and subjected to a solvatochromic study in which the positions of the Q-bands of each solvent were analyzed. Both macrocycles were studied using electrochemical measurements. In the voltammogram of zinc(II) tribenzoporphyrazine with 4-(3,5-dibutoxycarbonylphenoxy)butylthio substituents, two reduction peaks and one oxidation peak were observed in the electrochemical window between −2.0 V and +1.0 V, whereas the second oxidation peak was not noted in the CV scans. The evolution of this peak was observed at the boundary of the electrochemical window in the DPV scan. The CV and DPV studies of zinc(II) tribenzoporphyrazine with 4-[3,5-di(hydroxymethyl)phenoxy]butylthio substituents revealed four redox peaks: two reductions and two oxidations in the analyzed potential window. The electrochemical bandgap, Egap, of both zinc(II) tribenzoporphyrazines presented the same value of 1.5 eV. What is more, all oxidation and reduction processes for both macrocycles were diffusion-controlled due to a linear correlation of the peak currents of the redox pairs versus the square root scan rate. In the photochemical assessment of the singlet oxygen generation, both zinc(II) tribenzoporphyrazines revealed moderate to high quantum yield generation values of 0.24 and 0.59 in DMSO. The results of the Microtox® bioluminescence assay showed that the newly obtained zinc(II) macrocycles can be regarded as potential photosensitizers for further applications in medicine, while the electrochemical assessment proved that these molecules may be regarded as useful for new technology development.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/app12136825/s1. Figure S1. NMR data of 6: 1H and (13C) chemical shift values [ppm] and key correlations observed in NMR spectra. Bold lines: 1H-1H COSY; Arrows: 1H-13C HMBC. Figure S2. NMR data of 7: 1H and (13C) chemical shift values [ppm] and key correlations observed in NMR spectra. Bold lines: 1H-1H COSY; Arrows: 1H-13C HMBC. Table S1. 1H and 13C NMR data obtained for 6 including key correlations determined from 1H-1H COSY, 1H-13C HSQC and 1H-13C HMBC spectra. Table S2. 1H and 13C NMR data obtained for 7 including key correlations determined from 1H-1H COSY, 1H-13C HSQC and 1H-13C HMBC spectra.

Author Contributions

Conceptualization, P.K. and T.G.; methodology, P.K., T.K. and D.T.M.; formal analysis, P.K., T.K. and D.T.M.; investigation, P.K., T.K. and D.T.M.; resources, T.G.; data curation, P.K.; writing—original draft preparation, P.K., T.K. and D.T.M.; writing—review and editing, P.K. and T.G.; supervision, T.G. and T.K.; project administration, T.G.; funding acquisition, T.G. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Science Centre, Poland, within grant No. 2020/39/O/NZ7/00351.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All the data produced in this study is contained in the manuscript text.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Rodríguez-Morgade, M.S.; Stuzhin, P.A. The Chemistry of Porphyrazines: An Overview. J. Porphyr. Phthalocyanines 2004, 8, 1129–1165. [Google Scholar] [CrossRef]
  2. Zong, H.; Sun, P.; Mirkin, C.A.; Barrett, A.G.M.; Hoffman, B.M. Varying the Electrochemical Potential and Thickness of Porphyrazine SAMs by Molecular Design. J. Phys. Chem. B 2009, 113, 14892–14903. [Google Scholar] [CrossRef] [PubMed]
  3. Motyka, M.; Steer, R.P.; Williams, C.C.; Lee, S.; Ghiggino, K.P. Concerning the Dual Emission of Porphyrazines Employed in Biomedical Imaging. Photochem. Photobiol. Sci. 2013, 12, 1086. [Google Scholar] [CrossRef] [PubMed]
  4. Miletin, M.; Zimcik, P.; Novakova, V. Photodynamic Properties of Aza-Analogues of Phthalocyanines. Photochem. Photobiol. Sci. 2018, 17, 1749–1766. [Google Scholar] [CrossRef] [PubMed]
  5. Novakova, V.; Donzello, M.P.; Ercolani, C.; Zimcik, P.; Stuzhin, P.A. Tetrapyrazinoporphyrazines and Their Metal Derivatives. Part II: Electronic Structure, Electrochemical, Spectral, Photophysical and Other Application Related Properties. Coord. Chem. Rev. 2018, 361, 1–73. [Google Scholar] [CrossRef]
  6. Dąbrowski, J.M.; Pucelik, B.; Regiel-Futyra, A.; Brindell, M.; Mazuryk, O.; Kyzioł, A.; Stochel, G.; Macyk, W.; Arnaut, L.G. Engineering of Relevant Photodynamic Processes through Structural Modifications of Metallotetrapyrrolic Photosensitizers. Coord. Chem. Rev. 2016, 325, 67–101. [Google Scholar] [CrossRef]
  7. Zhou, Z.; Zhang, L.; Zhang, Z.; Liu, Z. Advances in Photosensitizer-Related Design for Photodynamic Therapy. Asian J. Pharm. Sci. 2021, 16, 668–686. [Google Scholar] [CrossRef]
  8. O’Connor, A.E.; Gallagher, W.M.; Byrne, A.T. Porphyrin and Nonporphyrin Photosensitizers in Oncology: Preclinical and Clinical Advances in Photodynamic Therapy. Photochem. Photobiol. 2009, 85, 1053–1074. [Google Scholar] [CrossRef]
  9. Agostinis, P.; Berg, K.; Cengel, K.A.; Foster, T.H.; Girotti, A.W.; Gollnick, S.O.; Hahn, S.M.; Hamblin, M.R.; Juzeniene, A.; Kessel, D.; et al. Photodynamic Therapy of Cancer: An Update. CA Cancer J. Clin. 2011, 61, 250–281. [Google Scholar] [CrossRef]
  10. Stolarska, M.; Glowacka-Sobotta, A.; Ziental, D.; Dlugaszewska, J.; Falkowski, M.; Goslinski, T.; Sobotta, L. Photochemical Properties and Promising Activity against Staphylococci of Sulfanyl Porphyrazines with Dendrimeric Moieties. Inorg. Chim. Acta 2021, 521, 120321. [Google Scholar] [CrossRef]
  11. Skupin-Mrugalska, P.; Piskorz, J.; Goslinski, T.; Mielcarek, J.; Konopka, K.; Düzgüneş, N. Current Status of Liposomal Porphyrinoid Photosensitizers. Drug Discov. Today 2013, 18, 776–784. [Google Scholar] [CrossRef] [PubMed]
  12. Piskorz, J.; Mlynarczyk, D.T.; Szczolko, W.; Konopka, K.; Düzgüneş, N.; Mielcarek, J. Liposomal Formulations of Magnesium Sulfanyl Tribenzoporphyrazines for the Photodynamic Therapy of Cancer. J. Inorg. Biochem. 2018, 184, 34–41. [Google Scholar] [CrossRef] [PubMed]
  13. Sobotta, L.; Dlugaszewska, J.; Kasprzycki, P.; Lijewski, S.; Teubert, A.; Mielcarek, J.; Gdaniec, M.; Goslinski, T.; Fita, P.; Tykarska, E. In Vitro Photodynamic Activity of Lipid Vesicles with Zinc Phthalocyanine Derivative against Enterococcus Faecalis. J. Photochem. Photobiol. B Biol. 2018, 183, 111–118. [Google Scholar] [CrossRef]
  14. Darwish, W. Polymers for Enhanced Photodynamic Cancer Therapy: Phthalocyanines as a Photosensitzer Model. Polym. Adv. Technol. 2020, 32, 919–930. [Google Scholar] [CrossRef]
  15. Shilyagina, N.Y.; Peskova, N.N.; Lermontova, S.A.; Brilkina, A.A.; Vodeneev, V.A.; Yakimansky, A.V.; Klapshina, L.G.; Balalaeva, I.V. Effective Delivery of Porphyrazine Photosensitizers to Cancer Cells by Polymer Brush Nanocontainers. J. Biophoton. 2017, 10, 1189–1197. [Google Scholar] [CrossRef] [PubMed]
  16. Thakur, N.S.; Mandal, N.; Patel, G.; Kirar, S.; Reddy, Y.N.; Kushwah, V.; Jain, S.; Kalia, Y.N.; Bhaumik, J.; Banerjee, U.C. Co-Administration of Zinc Phthalocyanine and Quercetin via Hybrid Nanoparticles for Augmented Photodynamic Therapy. Nanomed. Nanotechnol. Biol. Med. 2021, 33, 102368. [Google Scholar] [CrossRef]
  17. Lucky, S.S.; Soo, K.C.; Zhang, Y. Nanoparticles in Photodynamic Therapy. Chem. Rev. 2015, 115, 1990–2042. [Google Scholar] [CrossRef]
  18. Lijewski, S.; Gierszewski, M.; Sobotta, L.; Piskorz, J.; Kordas, P.; Kucinska, M.; Baranowski, D.; Gdaniec, Z.; Murias, M.; Karolczak, J.; et al. Photophysical Properties and Photochemistry of a Sulfanyl Porphyrazine Bearing Isophthaloxybutyl Substituents. Dye. Pigment. 2015, 113, 702–708. [Google Scholar] [CrossRef]
  19. Klein, T.; Ziegler, T. First Example of an Octa-Glycoconjugated Magnesium(II)Porphyrazine. Tetrahedron Lett. 2016, 57, 495–497. [Google Scholar] [CrossRef]
  20. Mlynarczyk, D.T.; Lijewski, S.; Falkowski, M.; Piskorz, J.; Szczolko, W.; Sobotta, L.; Stolarska, M.; Popenda, L.; Jurga, S.; Konopka, K.; et al. Dendrimeric Sulfanyl Porphyrazines: Synthesis, Physico-Chemical Characterization, and Biological Activity for Potential Applications in Photodynamic Therapy. ChemPlusChem 2016, 81, 460–470. [Google Scholar] [CrossRef]
  21. Mlynarczyk, D.T.; Piskorz, J.; Popenda, L.; Stolarska, M.; Szczolko, W.; Konopka, K.; Jurga, S.; Sobotta, L.; Mielcarek, J.; Düzgüneş, N.; et al. S-Seco-Porphyrazine as a New Member of the Seco-Porphyrazine Family-Synthesis, Characterization and Photocytotoxicity against Cancer Cells. Bioorg. Chem. 2020, 96, 103634. [Google Scholar] [CrossRef] [PubMed]
  22. Sobotta, L.; Fita, P.; Szczolko, W.; Wrotynski, M.; Wierzchowski, M.; Goslinski, T.; Mielcarek, J. Functional Singlet Oxygen Generators Based on Porphyrazines with Peripheral 2,5-Dimethylpyrrol-1-Yl and Dimethylamino Groups. J. Photochem. Photobiol. A Chem. 2013, 269, 9–16. [Google Scholar] [CrossRef]
  23. Seotsanyana-Mokhosi, I.; Kuznetsova, N.; Nyokong, T. Photochemical Studies of Tetra-2,3-Pyridinoporphyrazines. J. Photochem. Photobiol. A Chem. 2001, 140, 215–222. [Google Scholar] [CrossRef]
  24. Ogunsipe, A.; Maree, D.; Nyokong, T. Solvent Effects on the Photochemical and Fluorescence Properties of Zinc Phthalocyanine Derivatives. J. Mol. Struct. 2003, 650, 131–140. [Google Scholar] [CrossRef] [Green Version]
  25. Chelminiak-Dudkiewicz, D.; Rybczynski, P.; Smolarkiewicz-Wyczachowski, A.; Mlynarczyk, D.T.; Wegrzynowska-Drzymalska, K.; Ilnicka, A.; Goslinski, T.; Marszałł, M.P.; Ziegler-Borowska, M. Photosensitizing Potential of Tailored Magnetite Hybrid Nanoparticles Functionalized with Levan and Zinc(II) Phthalocyanine. Appl. Surf. Sci. 2020, 524, 146602. [Google Scholar] [CrossRef]
  26. Linstead, R.P.; Whalley, M. 944. Conjugated Macrocylces. Part XXII. Tetrazaporphin and Its Metallic Derivatives. J. Chem. Soc. 1952, 4839–4846. [Google Scholar] [CrossRef]
  27. Montalban, A.G.; Lange, S.J.; Beall, L.S.; Mani, N.S.; Williams, D.J.; White, A.J.P.; Barrett, A.G.M.; Hoffman, B.M. Seco-Porphyrazines: Synthetic, Structural, and Spectroscopic Investigations. J. Org. Chem. 1997, 62, 9284–9289. [Google Scholar] [CrossRef]
  28. Höger, S. Methoxycarbonyl-Terminated Dendrons via the Mitsunobu Reaction: An Easy Way to Functionalized Hyperbranched Building Blocks. Synthesis 1997, 1997, 20–22. [Google Scholar] [CrossRef]
  29. Nostrum van, C.F.; Benneker, F.B.G.; Brussaard, H.; Kooijman, H.; Veldman, N.; Spek, A.L.; Schoonman, J.; Feiters, M.C.; Nolte, R.J.M. Dithiacrown Ether Substituted Porphyrazines: Synthesis, Single-Crystal Structure, and Control of Aggregation in Solution by Complexation of Transition-Metal Ions. Inorg. Chem. 1996, 35, 959–969. [Google Scholar] [CrossRef] [Green Version]
  30. Sibert, J.W.; Baumann, T.F.; Williams, D.J.; White, A.J.P.; Barrett, A.G.M.; Hoffman, B.M. Gemini-Porphyrazines: The Synthesis and Characterization of Metal-Capped Cis-and Trans -Porphyrazine Tetrathiolates. J. Am. Chem. Soc. 1996, 118, 10487–10493. [Google Scholar] [CrossRef]
  31. Araújo, A.R.L.; Tomé, A.C.; Santos, C.I.M.; Faustino, M.A.F.; Neves, M.G.P.M.S.; Simões, M.M.Q.; Moura, N.M.M.; Abu-Orabi, S.T.; Cavaleiro, J.A.S. Azides and Porphyrinoids: Synthetic Approaches and Applications. Part 2—Azides, Phthalocyanines, Subphthalocyanines and Porphyrazines. Molecules 2020, 25, 1745. [Google Scholar] [CrossRef] [PubMed]
  32. Pereira, G.F.M.; Tasso, T.T. From Cuvette to Cells: How the Central Metal Ion Modulates the Properties of Phthalocyanines and Porphyrazines as Photosensitizers. Inorg. Chim. Acta 2021, 519, 120271. [Google Scholar] [CrossRef]
  33. Salvati, A.; Ristori, S.; Pietrangeli, D.; Oberdisse, J.; Calamai, L.; Martini, G.; Ricciardi, G. Insertion of a Magnesium(II)-Octacarboranyl(Hexylsulfanyl) Porphyrazine into Liposomes: A Physico-Chemical Study. Biophys. Chem. 2007, 131, 43–51. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Bayliss, N.S. The Effect of the Electrostatic Polarization of the Solvent on Electronic Absorption Spectra in Solution. J. Chem. Phys. 1950, 18, 292–296. [Google Scholar] [CrossRef]
  35. Chemical Rubber Company. CRC Handbook of Chemistry and Physics: A Ready-Reference Book of Chemical and Physical Data, 78th ed.; Lide, D.R., Ed.; Edition 1997–1998; CRC Press: Boca Raton, FL, USA, 1997; ISBN 978-0-8493-0478-1. [Google Scholar]
  36. Rebis, T.; Lijewski, S.; Nowicka, J.; Popenda, L.; Sobotta, L.; Jurga, S.; Mielcarek, J.; Milczarek, G.; Goslinski, T. Electrochemical Properties of Metallated Porphyrazines Possessing Isophthaloxybutylsulfanyl Substituents: Application in the Electrocatalytic Oxidation of Hydrazine. Electrochim. Acta 2015, 168, 216–224. [Google Scholar] [CrossRef]
  37. Koczorowski, T.; Szczolko, W.; Teubert, A.; Goslinski, T. Sulfanyl Porphyrazines with Morpholinylethyl Periphery—Synthesis, Electrochemistry, and Photocatalytic Studies after Deposition on Titanium(IV) Oxide P25 Nanoparticles. Molecules 2021, 26, 2280. [Google Scholar] [CrossRef]
  38. Gierszewski, M.; Falkowski, M.; Sobotta, L.; Stolarska, M.; Popenda, L.; Lijewski, S.; Wicher, B.; Burdzinski, G.; Karolczak, J.; Jurga, S.; et al. Porphyrazines with Peripheral Isophthaloxyalkylsulfanyl Substituents and Their Optical Properties. J. Photochem. Photobiol. A Chem. 2015, 307, 54–67. [Google Scholar] [CrossRef]
  39. Mlynarczyk, D.T.; Dlugaszewska, J.; Falkowski, M.; Popenda, L.; Kryjewski, M.; Szczolko, W.; Jurga, S.; Mielcarek, J.; Goslinski, T. Tribenzoporphyrazines with Dendrimeric Peripheral Substituents and Their Promising Photocytotoxic Activity against Staphylococcus Aureus. J. Photochem. Photobiol. B Biol. 2020, 204, 111803. [Google Scholar] [CrossRef]
Scheme 1. Reagents and conditions for the synthesis of compounds 17: (i) K2CO3, DMF, rt, 48 h; (ii) K2CO3, DMF, rt, 48 h [20]; (iii) Mg(nOC4H9)2, nBuOH, reflux, 24 h [20]; (iv) LiAlH4, THF, 0 °Crt, 2 h [20]; (v) CF3COOH, room temperature, 30 min [21]; (vi) (CH3COO)2Zn, DMF, 70 °C, 24 h; (vii) LiAlH4, THF, 0 °Crt, 40 min; rt—room temperature.
Scheme 1. Reagents and conditions for the synthesis of compounds 17: (i) K2CO3, DMF, rt, 48 h; (ii) K2CO3, DMF, rt, 48 h [20]; (iii) Mg(nOC4H9)2, nBuOH, reflux, 24 h [20]; (iv) LiAlH4, THF, 0 °Crt, 2 h [20]; (v) CF3COOH, room temperature, 30 min [21]; (vi) (CH3COO)2Zn, DMF, 70 °C, 24 h; (vii) LiAlH4, THF, 0 °Crt, 40 min; rt—room temperature.
Applsci 12 06825 sch001
Figure 1. The variation in the Q-band in various solvents for 6 (a) and 7 (b).
Figure 1. The variation in the Q-band in various solvents for 6 (a) and 7 (b).
Applsci 12 06825 g001
Figure 2. Plots of the wavelength of the Q-band maximum absorbance vs. the rational function of the solvent’s refractive index (1/F) for 6 (a) and 7 (b). Solvents used: (1) dichloromethane, (2) acetone, (3) chloroform, (4) diethyl ether, (5) ethyl acetate, (6) acetonitrile, (7) toluene, (8) THF, (9) 1,4-dioxane, (10) 1-butanol *, (11) DMF, and (12) DMSO; *—correlation was not found, therefore not added to the figure.
Figure 2. Plots of the wavelength of the Q-band maximum absorbance vs. the rational function of the solvent’s refractive index (1/F) for 6 (a) and 7 (b). Solvents used: (1) dichloromethane, (2) acetone, (3) chloroform, (4) diethyl ether, (5) ethyl acetate, (6) acetonitrile, (7) toluene, (8) THF, (9) 1,4-dioxane, (10) 1-butanol *, (11) DMF, and (12) DMSO; *—correlation was not found, therefore not added to the figure.
Applsci 12 06825 g002
Figure 3. Plots of the wavelength of the Q-band maximum absorbance vs. the dipole moment of solvents for 6 (a) and 7 (b). Solvents used: (1) dichloromethane, (2) acetone, (3) chloroform, (4) diethyl ether *, (5) ethyl acetate, (6) acetonitrile, (7) toluene, (8) THF, (9) 1,4-dioxane *, (10) 1-butanol *, (11) DMF, and (12) DMSO; *—correlation was not found, therefore not added to the figure.
Figure 3. Plots of the wavelength of the Q-band maximum absorbance vs. the dipole moment of solvents for 6 (a) and 7 (b). Solvents used: (1) dichloromethane, (2) acetone, (3) chloroform, (4) diethyl ether *, (5) ethyl acetate, (6) acetonitrile, (7) toluene, (8) THF, (9) 1,4-dioxane *, (10) 1-butanol *, (11) DMF, and (12) DMSO; *—correlation was not found, therefore not added to the figure.
Applsci 12 06825 g003
Figure 4. The CV (a) and DPV (b) voltammograms of 6 in DCM/0.1M TBAP. DPV parameters: modulation amplitude 20 mV, step rate 5 mV × s−1.
Figure 4. The CV (a) and DPV (b) voltammograms of 6 in DCM/0.1M TBAP. DPV parameters: modulation amplitude 20 mV, step rate 5 mV × s−1.
Applsci 12 06825 g004
Figure 5. The CV (a) and DPV (b) voltammograms of 7 in DCM/0.1M TBAP. DPV parameters: modulation amplitude 20 mV, step rate 5 mV × s−1.
Figure 5. The CV (a) and DPV (b) voltammograms of 7 in DCM/0.1M TBAP. DPV parameters: modulation amplitude 20 mV, step rate 5 mV × s−1.
Applsci 12 06825 g005
Figure 6. Peak current vs. square root scan rate for redox peaks of Pzs 6 (a) and 7 (b).
Figure 6. Peak current vs. square root scan rate for redox peaks of Pzs 6 (a) and 7 (b).
Applsci 12 06825 g006
Figure 7. Changes in the UV-Vis spectrum of 6 and DPBF mixture in DMSO during irradiation at 665 nm.
Figure 7. Changes in the UV-Vis spectrum of 6 and DPBF mixture in DMSO during irradiation at 665 nm.
Applsci 12 06825 g007
Figure 8. Changes in the UV-Vis spectrum of 7 and DPBF mixture in DMSO during irradiation at 665 nm.
Figure 8. Changes in the UV-Vis spectrum of 7 and DPBF mixture in DMSO during irradiation at 665 nm.
Applsci 12 06825 g008
Figure 9. Changes in the Aliivibrio fischeri cell viability upon exposure to the tested porphyrazines 3, 4, 6, and 7 at 10−4 or 10−5 concentrations.
Figure 9. Changes in the Aliivibrio fischeri cell viability upon exposure to the tested porphyrazines 3, 4, 6, and 7 at 10−4 or 10−5 concentrations.
Applsci 12 06825 g009
Table 1. Soret bands and Q-bands in the UV-Vis spectra of tribenzoporphyrazine derivatives 6 and 7 recorded in various solvents.
Table 1. Soret bands and Q-bands in the UV-Vis spectra of tribenzoporphyrazine derivatives 6 and 7 recorded in various solvents.
67
SOLVENTλ2/nm (Soret Band)λ1/nm (Q-Band)λ2/nm (Soret Band)λ1/nm (Q-Band)
dichloromethane352692358723
acetone354685356693
chloroform353693357719
diethyl ether353685357713
ethyl acetate354686355696
acetonitrile356686356687
toluene361701360707
thf355688356689
1,4-dioxane346685357682
1-butanol347682354683
dmf364682366682
dmso337681338682
Table 2. The variation in the Q-band for 6 and 7 in different solvents (dipole moments and refractive indexes [24,35]).
Table 2. The variation in the Q-band for 6 and 7 in different solvents (dipole moments and refractive indexes [24,35]).
SolventRefractive Index (nD)Dipole Moment (µ)Q-Band (λmax, nm) 6Q-Band (λmax, nm) 7
dichloromethane1.4451.60692723
acetone1.3592.88685693
chloroform1.4461.04693719
diethyl ether1.3521.15685713
ethyl acetate1.3721.78686696
acetonitrile1.3443.92686687
toluene1.4970.37701707
THF1.4071.75688689
1,4-dioxane1.4220685682
1-butanol1.3991.66682683
DMF1.4303.82682682
DMSO1.4783.96681682
Table 3. The electrochemical data of porphyrazines 6 and 7.
Table 3. The electrochemical data of porphyrazines 6 and 7.
PzRed2Red1Oxd1Oxd2EgapRef.
6−1.50 V−1.22 V0.28 V-1.50 eVThis work
7−1.39 V−1.12 V0.38 V0.61 V1.50 eVThis work
Sym ZnPz 1−1.24 V−1.01 V0.67 V-1.68 eV[36]
Sym ZnPz 2−1.34 V−0.74 V0.53 V-1.27 eV[37]
1 2,3,7,8,12,13,17,18–octakis[4-(3,5-dibutoxycarbonylphenoxy)butylthio]porphyrazinato zinc(II). 2 2,3,7,8,12,13,17,18–octakis[2-(morpholin-4-yl)ethylsulfanyl]porphyrazinato zinc(II).
Table 4. Quantum yields of singlet oxygen generation by Pzs 3, 4, 6, and 7 in DMSO.
Table 4. Quantum yields of singlet oxygen generation by Pzs 3, 4, 6, and 7 in DMSO.
PZSINGLET OXYGEN GENERATION
Singlet oxygen quantum yield [Φ] [a]
3 [20]0.05
4 [20]0.20
60.24
70.59
[a] error ≤ 0.01
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Koza, P.; Koczorowski, T.; Mlynarczyk, D.T.; Goslinski, T. Zinc(II) Sulfanyltribenzoporphyrazines with Bulky Peripheral Substituents—Synthesis, Photophysical Characterization, and Potential Photocytotoxicity. Appl. Sci. 2022, 12, 6825. https://doi.org/10.3390/app12136825

AMA Style

Koza P, Koczorowski T, Mlynarczyk DT, Goslinski T. Zinc(II) Sulfanyltribenzoporphyrazines with Bulky Peripheral Substituents—Synthesis, Photophysical Characterization, and Potential Photocytotoxicity. Applied Sciences. 2022; 12(13):6825. https://doi.org/10.3390/app12136825

Chicago/Turabian Style

Koza, Patrycja, Tomasz Koczorowski, Dariusz T. Mlynarczyk, and Tomasz Goslinski. 2022. "Zinc(II) Sulfanyltribenzoporphyrazines with Bulky Peripheral Substituents—Synthesis, Photophysical Characterization, and Potential Photocytotoxicity" Applied Sciences 12, no. 13: 6825. https://doi.org/10.3390/app12136825

APA Style

Koza, P., Koczorowski, T., Mlynarczyk, D. T., & Goslinski, T. (2022). Zinc(II) Sulfanyltribenzoporphyrazines with Bulky Peripheral Substituents—Synthesis, Photophysical Characterization, and Potential Photocytotoxicity. Applied Sciences, 12(13), 6825. https://doi.org/10.3390/app12136825

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop